42 related articles for article (PubMed ID: 15380198)
1. Quantitative structure-activity relationships of imidazole-containing farnesyltransferase inhibitors using different chemometric methods.
Shayanfar A; Ghasemi S; Soltani S; Asadpour-Zeynali K; Doerksen RJ; Jouyban A
Med Chem; 2013 May; 9(3):434-48. PubMed ID: 22920090
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, central nervous system activity and structure-activity relationships of novel 1-(1-Alkyl-4-aryl-4,5-dihydro-1H-imidazo)-3-substituted urea derivatives.
Szacoń E; Rządkowska M; Kaczor AA; Kędzierska E; Fidecka S; Matosiuk D
Molecules; 2015 Feb; 20(3):3821-40. PubMed ID: 25730390
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of biphenyl proteomimetics as estrogen receptor-alpha coactivator binding inhibitors.
Williams AB; Weiser PT; Hanson RN; Gunther JR; Katzenellenbogen JA
Org Lett; 2009 Dec; 11(23):5370-3. PubMed ID: 19902964
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial Chrysophaentin Analogs Identified from Laboratory Cultures of the Marine Microalga Chrysophaeum taylorii.
Davison JR; Bewley CA
J Nat Prod; 2019 Jan; 82(1):148-153. PubMed ID: 30623657
[TBL] [Abstract][Full Text] [Related]
5. Imidazole-containing farnesyltransferase inhibitors: 3D quantitative structure-activity relationships and molecular docking.
Xie A; Odde S; Prasanna S; Doerksen RJ
J Comput Aided Mol Des; 2009 Jul; 23(7):431-48. PubMed ID: 19479325
[TBL] [Abstract][Full Text] [Related]
6. Farnesyltransferase inhibitors: an overview of the results of preclinical and clinical investigations.
Brunner TB; Hahn SM; Gupta AK; Muschel RJ; McKenna WG; Bernhard EJ
Cancer Res; 2003 Sep; 63(18):5656-68. PubMed ID: 14522880
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of 4-[(3-methyl-3H-imidazol-4-yl)-(2-phenylethynyl-benzyloxy)-methyl]-benzonitrile as novel farnesyltransferase inhibitor.
Lin NH; Wang L; Cohen J; Gu WZ; Frost D; Zhang H; Rosenberg S; Sham H
Bioorg Med Chem Lett; 2003 Nov; 13(21):3821-5. PubMed ID: 14552788
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of 4-[3-biphenyl-2-yl-1-hydroxy-1-(3-methyl-3H-imidazol-4-yl)-prop-2-ynyl]-1-yl-benzonitrile as novel farnesyltransferase inhibitor.
Lin NH; Wang L; Cohen J; Gu WZ; Frost D; Zhang H; Rosenberg S; Sham H
Bioorg Med Chem Lett; 2003 Apr; 13(7):1293-6. PubMed ID: 12657267
[TBL] [Abstract][Full Text] [Related]
9. Novel and selective imidazole-containing biphenyl inhibitors of protein farnesyltransferase.
Curtin ML; Florjancic AS; Cohen J; Gu WZ; Frost DJ; Muchmore SW; Sham HL
Bioorg Med Chem Lett; 2003 Apr; 13(7):1367-71. PubMed ID: 12657284
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and activity of 1-aryl-1'-imidazolyl methyl ethers as non-thiol farnesyltransferase inhibitors.
Li Q; Wang GT; Li T; Gwaltney SL; Woods KW; Claiborne A; Wang X; Gu W; Cohen J; Stoll VS; Hutchins C; Frost D; Rosenberg SH; Sham HL
Bioorg Med Chem Lett; 2004 Nov; 14(21):5371-6. PubMed ID: 15454229
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and biological activity of 4-[(4-cyano-2-arylbenzyloxy)-(3-methyl-3H-imidazol-4-yl)methyl]benzonitriles as potent and selective farnesyltransferase inhibitors.
Wang L; Wang GT; Wang X; Tong Y; Sullivan G; Park D; Leonard NM; Li Q; Cohen J; Gu WZ; Zhang H; Bauch JL; Jakob CG; Hutchins CW; Stoll VS; Marsh K; Rosenberg SH; Sham HL; Lin NH
J Med Chem; 2004 Jan; 47(3):612-26. PubMed ID: 14736242
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of 1-benzyl-5-(3-biphenyl-2-yl-propyl)-1H-imidazole as novel farnesyltransferase inhibitor.
Lin NH; Wang L; Wang X; Wang GT; Cohen J; Gu WZ; Zhang H; Rosenberg SH; Sham HL
Bioorg Med Chem Lett; 2004 Oct; 14(20):5057-62. PubMed ID: 15380198
[TBL] [Abstract][Full Text] [Related]
13. Farnesyltransferase inhibitors as anticancer agents: current status.
Zhu K; Hamilton AD; Sebti SM
Curr Opin Investig Drugs; 2003 Dec; 4(12):1428-35. PubMed ID: 14763128
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
